|
|
Line 317: |
Line 317: |
| <br> | | <br> |
|
| |
|
| ===Patricia Kovacevic, J.D.=== | | ===Patricia Kovacevic, JD=== |
| *[https://twitter.com/patriciakova Follow on Twitter] | | *[https://twitter.com/patriciakova Follow on Twitter] / [https://tobaccoreporter.com/2022/04/05/women-in-tobacco-to-meet-in-paris/ Photo] / [https://regulationstrategy.com/patricia-kovacevic/ Bio] / [https://twitter.com/patriciakova/status/1610989194410692608 Quote Source] |
| *(Disclosures...) | | *Disclosures: General Counsel and Chief Compliance Officer, Nicopure Labs, 2015 - 2020, General Counsel to Lorrilard and PMI 2004 - 2015 |
| <br> | | <br> |
| | [[file:UK US Patricia Kovacevic, JD.png|center]] |
| <br> | | <br> |
| | |
| ===Floe Foxon, BSc=== | | ===Floe Foxon, BSc=== |
| *[https://twitter.com/FloeFoxon Follow on Twitter] / [https://twitter.com/FloeFoxon/status/1448302299013582849 Quote Source] / [https://floefoxon.github.io/ Photo] / [https://www.pinneyassociates.com/team/floe-foxon/ Bio] | | *[https://twitter.com/FloeFoxon Follow on Twitter] / [https://twitter.com/FloeFoxon/status/1448302299013582849 Quote Source] / [https://floefoxon.github.io/ Photo] / [https://www.pinneyassociates.com/team/floe-foxon/ Bio] |